Listen to the article
In a significant settlement announced this week, insurance giant Aetna has agreed to pay $117.7 million to resolve allegations that it violated the False Claims Act by submitting inaccurate diagnosis codes for Medicare Advantage Plan enrollees, according to the Department of Justice.
The case highlights growing concerns about potential fraud in the Medicare Advantage program, which serves millions of seniors and disabled Americans. Federal prosecutors alleged that Aetna’s practices resulted in fraudulent overpayments, effectively diverting limited government healthcare resources.
“The government pays Medicare Advantage Organizations to facilitate vital healthcare to our seniors and other vulnerable citizens,” said United States Attorney General David Metcalf in a statement. “When corporations or individuals threaten the Medicare Advantage program by diverting those limited government resources through fraud, waste or abuse, we will continue to pursue all available remedies against them.”
The Medicare Advantage program operates on a risk-adjustment model, where private insurers submit diagnosis codes to the Centers for Medicare & Medicaid Services (CMS) to determine monthly payments. This system is designed to provide higher compensation to plans that cover sicker patients with more complex needs, who typically require more expensive care.
According to the lawsuit, Aetna manipulated this system to its financial advantage. In 2015, the insurer received medical charts from contracted provider partners for individuals enrolled in its Medicare Advantage plans. While these charts are typically used to conduct reviews before submitting diagnosis codes to CMS, federal prosecutors alleged that Aetna submitted additional diagnosis codes “that the healthcare providers had not reported for the beneficiaries to obtain additional payments from CMS.”
The federal government further claimed that Aetna used chart reviews selectively to seek additional payments while failing to use those same reviews when providing information about potential overpayments. This practice accounts for $106.2 million of the total settlement.
The remaining $11.5 million resolves separate allegations that between 2018 and 2023, Aetna knowingly submitted or failed to delete inaccurate diagnosis codes for morbid obesity among individuals without the necessary Body Mass Index (BMI) documentation to support such diagnoses, resulting in further overpayments.
This settlement comes amid increased scrutiny of the Medicare Advantage program, which has grown dramatically in recent years and now serves approximately 30 million Americans, or about half of all Medicare beneficiaries. The federal government pays more than $530 billion annually to private insurers participating in the program.
“Medicare Advantage relies on accurate reporting and attempts to manipulate the system undermine both the program’s integrity and the beneficiaries it serves,” said Acting Deputy Inspector General for Investigations Scott J. Lampert of the U.S. Department of Health and Human Services, Office of Inspector General. “Today’s settlement makes clear that no company is beyond accountability, no matter how large or well known.”
The Aetna case represents part of a broader pattern of enforcement actions against major health insurers. In recent years, several other insurance companies have faced similar allegations related to Medicare Advantage billing practices, with settlements often reaching into the hundreds of millions of dollars.
Industry analysts note that as Medicare Advantage enrollment continues to grow and federal spending on the program increases, regulators are intensifying their oversight of risk-adjustment practices and documentation requirements.
Assistant Attorney General Brett A. Shumate of the Justice Department’s Civil Division emphasized the government’s commitment to ongoing enforcement: “We will continue to hold accountable insurers that knowingly submit inaccurate or unsupported diagnoses to improperly inflate reimbursement.”
The settlement does not include any admission of liability by Aetna, which is standard in such agreements, but the substantial payment reflects the seriousness of the allegations and the government’s determination to protect the integrity of the Medicare Advantage program.
Fact Checker
Verify the accuracy of this article using The Disinformation Commission analysis and real-time sources.
14 Comments
As someone with a family member in a Medicare Advantage plan, I’m relieved to see the government cracking down on fraudulent billing practices. Protecting vulnerable enrollees should be the top priority.
It’s good to see the government taking these allegations seriously and pursuing significant penalties. Medicare fraud erodes public trust and diverts critical resources away from patient care. This should serve as a deterrent for other insurers.
Absolutely. The Medicare Advantage program needs to be a model of integrity, not an avenue for exploitation. Robust enforcement is essential to maintaining that standard.
This settlement is a significant win for Medicare beneficiaries and taxpayers. Fraud and abuse in the Medicare Advantage program must be rooted out to ensure the program’s sustainability and protect vulnerable enrollees.
I agree, the government needs to maintain vigilance over these managed care programs to prevent exploitation. Every dollar lost to fraud is one less available for patient care.
This case highlights the complexities involved in administering the Medicare Advantage program. While these private plans can provide valuable options, the government must remain vigilant to ensure taxpayer funds are used appropriately.
It’s troubling to see a major insurer like Aetna engaging in these kinds of practices. While the financial penalty is substantial, I hope this sends a strong message and leads to improved compliance across the industry.
Absolutely. Insurers need to be held accountable when they try to game the system at the expense of taxpayers and beneficiaries. Transparency and integrity are essential in these programs.
The Medicare Advantage program has expanded rapidly in recent years, so it’s critical that the government closely monitors these private plans for potential fraud or overbilling. This settlement underscores the need for rigorous oversight.
This settlement is a reminder that the government must stay vigilant in overseeing the Medicare Advantage program. Ensuring accurate diagnosis coding and appropriate payments is crucial to the program’s long-term sustainability.
Agreed. The risk-adjustment model is intended to provide fair reimbursement, but it can be easily abused. Rigorous auditing and enforcement are essential to maintain the integrity of the system.
While the financial penalty is substantial, I hope this case also leads to meaningful reforms and improved compliance within the Medicare Advantage industry. Seniors and taxpayers deserve to have confidence in these vital healthcare programs.
As a Medicare beneficiary, I’m glad to see the government taking action to protect the program’s integrity. Overpayments and fraudulent billing practices undermine the entire system and reduce resources for patient care.
I agree, Medicare beneficiaries deserve to have confidence that the system is working as intended. Rooting out fraud should be an ongoing priority for policymakers and regulators.